Huo T N, Wu S P, Chen W, Tang Y W, Fang R H
Department of Surgery, Veterans General Hospital, Taipei, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1993 May;51(5):355-60.
Sweat gland carcinoma is a rare malignancy of the skin appendage. Surgeons and pathologists have limited experience with such tumor. Various classifications and diagnostic identifications lead to easy confusion with other metastatic lesions. Eight cases of sweat gland carcinoma were collected from 1020 cases of primary skin malignancies seen at the Veterans General Hospital-Taipei over the past 20 years. After a careful review of the clinical history and histopathology files, as well as immunohistochemical stains of CEA and S-100 protein, only three cases were proved to be sweat gland carcinomas, accounting for less than 0.3% of the primary tumors of skin. All three cases were eccrine histology in type. Two cases were CEA positive, and one case was positive with S-100 protein stain. Five cases which were excluded were negative to CEA and S-100 protein analysis. Thus it is suggested that sweat gland carcinoma should receive more accurate differential diagnosis from other skin malignancies, particularly metastatic tumors. Immunohistochemical analysis could help differential diagnosis. Treatment modalities of sweat gland carcinoma base mainly upon adequate wide surgical excision.
汗腺癌是一种罕见的皮肤附属器恶性肿瘤。外科医生和病理学家对这类肿瘤的经验有限。各种分类和诊断识别容易导致与其他转移性病变混淆。在过去20年台北荣民总医院所见的1020例原发性皮肤恶性肿瘤中收集到8例汗腺癌。在仔细回顾临床病史、组织病理学档案以及CEA和S-100蛋白免疫组化染色后,仅3例被证实为汗腺癌,占皮肤原发性肿瘤的比例不到0.3%。所有3例均为小汗腺组织学类型。2例CEA阳性,1例S-100蛋白染色阳性。被排除的5例经CEA和S-100蛋白分析为阴性。因此,建议汗腺癌应与其他皮肤恶性肿瘤,特别是转移性肿瘤进行更准确的鉴别诊断。免疫组化分析有助于鉴别诊断。汗腺癌的治疗方式主要基于充分的广泛手术切除。